For instance, the HER2 overexpression rate was reported to vary between 38% to 67% in mucoepidermoid carcinomas (MEC) and 30% to 77% in adenoid cystic carcinomas (ACC) in different studies. Here, ERBB2 is linked to mucoepidermoid carcinoma.